Firms’ ability to raise drug prices is firmly intact despite pushback from health insurers and scrutiny by U.S. lawmakers. More than two-thirds of the 20 largestpharmaceutical companies said price increases boosted sales of their biggest products in the first quarter.
from WSJ.com: US Business http://ift.tt/29S9egz
via IFTTT
No comments:
Post a Comment